Capgras syndrome in children and adolescents: A systematic review.

Adolescents Antipsychotics Capgras Children OCD Schizophrenia

Journal

General hospital psychiatry
ISSN: 1873-7714
Titre abrégé: Gen Hosp Psychiatry
Pays: United States
ID NLM: 7905527

Informations de publication

Date de publication:
06 May 2024
Historique:
received: 01 04 2024
revised: 01 05 2024
accepted: 01 05 2024
medline: 9 5 2024
pubmed: 9 5 2024
entrez: 8 5 2024
Statut: aheadofprint

Résumé

To improve understanding of Capgras syndrome (CS) in the pediatric population, this study investigates its clinical features and discerns similarities and differences compared to CS in adults. We conducted a descriptive systematic review of case reports following PRISMA guidelines, including cases of pediatric patients with CS. Patient demographics, medical and psychiatric history, imposter identity, underlying diagnosis, clinical manifestation, treatments, and outcomes were extracted and analyzed. We included 37 articles comprising 38 cases. The median age of patients was 15, with 23 (60.5%) being male. The most prevalent underlying diagnoses were schizophrenia spectrum and other psychotic disorders (47.3%). Imposter identity involved parents in 32 cases (84.2%). Associated symptoms included persecutory delusions (63.1%), auditory hallucinations (42.1%), aggression (31.5%), and depression (21.0%). There is a significant gap in our understanding of CS, particularly in pediatric patients. This is the first systematic review of CS in pediatric patients, encompassing all cases found in English literature since 1923.

Identifiants

pubmed: 38718719
pii: S0163-8343(24)00084-7
doi: 10.1016/j.genhosppsych.2024.05.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

32-40

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no conflict of interest.

Auteurs

Ron Walfisch (R)

The Child Psychiatry Division, Edmond and Lily Safra Children's Hospital, Sheba Medical Centre, Tel Hashomer, Ramat Gan, Israel. Electronic address: dr.ronwalfisch@gmail.com.

Polina Perlman Danieli (PP)

The Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: polina.perlman@camh.ca.

Mariela Mosheva (M)

The Child Psychiatry Division, Edmond and Lily Safra Children's Hospital, Sheba Medical Centre, Tel Hashomer, Ramat Gan, Israel; The Faculty of Medicine & Health Sciences, Tel Aviv University, Tel Aviv, Israel. Electronic address: mariela.moshava@sheba.gov.il.

Yehonathan Hochberg (Y)

The Faculty of Medicine & Health Sciences, Tel Aviv University, Tel Aviv, Israel. Electronic address: yehonathanh1@mail.tau.ac.il.

Tal Shilton (T)

The Child Psychiatry Division, Edmond and Lily Safra Children's Hospital, Sheba Medical Centre, Tel Hashomer, Ramat Gan, Israel; The Faculty of Medicine & Health Sciences, Tel Aviv University, Tel Aviv, Israel. Electronic address: tal.shilton@sheba.health.gov.il.

Doron Gothelf (D)

The Child Psychiatry Division, Edmond and Lily Safra Children's Hospital, Sheba Medical Centre, Tel Hashomer, Ramat Gan, Israel; The Faculty of Medicine & Health Sciences, Tel Aviv University, Tel Aviv, Israel; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. Electronic address: gothelf@tauex.tau.ac.il.

Classifications MeSH